1) Telomeres: why do they shorten? And how does the cell make them longer?
2) (i) describe prokaryote protein formation process
(ii) how do eukaryotes make hnRNA? List the things that must be done for hnRNA to become mature mRNA. 3) What is RNA interference? Briefly describe how siRNA works. 4) (i) describe the differences between qualitative and quantitative genetics (ii) why do some anomalies which should be multifactorial in inheritance display differences in occurrence in different sexes? 5) What is antigen shift in influenza virus and how does it come about? ---------------------------------------------------------------------------- 1. Telomeres are highly repetive sequences found at the end of chromosomes. During DNA replication, RNA primers are located at the ends of DNA strand (and several primers are present in the lagging strand). When the RNA primers are substituted by DNA, via nick translation, a problem arises since there is no DNA upstream from the first RNA primer, and so this primer cannot be replaced. This results in chromosome shortening. Telomeres are made longer by the enzyme Telomerase. Telomerase adds the same, repetitive, 6 nucleotide sequence to the end of the telomeres so as to keep on elongating them. 2. (i) Prokaryotic protein synthesis starts with mature mRNA formed by the transcription of DNA to pre-mRNA, and post-transcriptional modification of the pre-mRNA into mRNA if applicable. Two, irreguarly shaped, ribosomal sub units (one large, one small) join to form the P, A and E sites, and the groove for the mRNA. As the mRNA is read in codons (3-set of nucleotides), corresponding tRNA, containing the suitable anti-codon enter the first site, the A site, and cause their attach amino acid to add onto the forming polypeptide chain. The empty tRNA exits the ribosome from the E site; the polypeptide chain is on the P site and new tRNA enters from the A site. Release factors cause the the polypeptide chain is released, post translational modification and folding, usually with the help of chaperones like heat schock protein (HSP) 70 and 60 occurs, to form the final protein product. (ii) hnRNA, or pre-mRNA is the raw product of transcription. Transcription is the process whereby a parental DNA strand acts as a template for the formation of the pre-mRNA. The process involves ADD REST TONIGHT. 3. RNA interference is a type of RNA modification therapy, other types being the use of antisense oligonucleotides and the use of ribozymes. It is useful as it disrupts RNA which is responsible for a wide range of diseases, including HIV. RNA makes use of siRNA, or short interference RNA, which is a short piece of double stranded RNA which is capable of entering the cell and disrupt the process of mRNA translation and also causes mRNA degradation. siRNA interference works in the following manner: The double-standed RNA (dsRNA) enters the cell via a medium, such as a lipoprotein or exosome. The dsRNA is cleaved by the enzyme called dicer into anti-sense and sense siRNA. Sense siRNA is degraded and the antisense siRNA forms a protein complex called RNA-Induced Silencing Complex (RISC). The RISC then causes degradation of the mRNA present. 4. (i) Qualitative: - Single gene inheritance - Characters of kind - Examples: Eye colour, Hair colour - Discontinuous variation - Environmental factors not important. - Concerned with individual matings Quantitative: - Polygenic inheritance - Characters of degree - Examples: Height, weight - Continuous variation - Environmental factors very important - Concerned with population matings (ii) This is not caused by sex chromosomes. Rather, it is caused by the fact that sexes have different physiologies. That is, the environmental factor differs (internal environment). For example, in the case of height, males tend to be ~3cm taller than females, even if the same genes are present and if they liver in the same environment. The difference in height is caused by the fact that males have more growth hormone than females and so are naturally slightly taller. When speaking of diesease, the same principle applies. Due to physiological differences between males and females, it can be taken that the distribution curves for genotypic liability to a condition are the same, but the threshold differs, making one sex more likely to get a certain condition than the other sex. 5. In the Influenza virus, several types of antigens exist: H1, H2, H3, N1, N2. Antigen shift is the process by which the antigens present on the surface of the influenza virus rapidly shifts, for example from H1N1 to H3N2. It occurs from a superinfection. This is when 2 virus strains are present in the same animal. When this occurs, the 8 RNA genes which are incorporated into the viroid seem to be random, therefore resulting in any mixture of RNA genes between the two original viruses, causing a new virus to form with a mixture of the two original viruses. --------------------------------------------------------------------------- 2012 paper: 1. The lagging strand is antiparallel to the leading stranding, and is in the 3' to 5' direction. Since synthesis occurs in a 5' to 3' direction, this strand isn't synthesized continuously like the leading strand. Instead, the lagging strand is synthesized in fragments called Okazaki fragments. An RNA primer is used to synthesize the first fragment, after which another RNA primer is placed further downstream and synthesis occurs until the first primer has been reached. This repeats, forming numerous fragments. The RNA primers are replaced by DNA, a process called nick translation which occurs due to DNA Pol I, after which DNA Ligase joins the fragments together to form the daughter strand. 2. Steroid hormone - Steroid hormones may modify gene expression, either by enhancing or repressing it. They are fat soluble and work by binding to receptors, either on the cell surface or in the cytoplasm, which then forms transcription factors. Promoter - Promoters are a short sequence of DNA that is present somewhere on the same gene and increases transcription of the gene towards its maximum potential. DNA Methylation - DNA Methylation is involved in genomic imprinting. What the methylation does is that is block the expression of a particular gene. Males and females methylate different genes, and this genomic imprinting is involved in diseases such as Prader-Willi syndrome and Angelman syndrome. Chromatin remodelling - Chromatin remodelling is the change in the chromatin from 'closed' to 'open', where 'open' chromatin implies that the chromatin is more loosely wound and can therefore participate in DNA synthesis or transcription of RNA. Alternate splicing - Alternate splicing is an important post-transcriptional modification of pre-mRNA where introns are excised from the gene. It is important because, apart from creating a function gene, it also explains how one gene can code for many proteins, as some exons may be excised in some proteins but not in others. 3. a) Mitochondrial DNA - The DNA within mitochondria. It is 16.6kb long. It has several distinct characteristic, such as the fact that it lacks introns, has a high rate of mutation (due to ROS, lack of histones, inefficient DNA repair mechanisms, no proof-reading, etc.) and the fact that it shows maternal inheritance.
b) Recessive epistasis - Recessive epistasis is a type of interaction between two genes, not located on the same locus, meaning that the expression of one gene may be dependent on the other gene. In recessive epistasis, if the genotype of an allele is aa, it may prevent the expression of an allele Bb, or BB. The 9:3:3:1 ratio is modified to 9:3:4. c) Single nucleotide polymorphisms - SNPs are single nucleotides which show polymorphism, that is, there is a significant variation in a population in that there are at least two differ- ent variants. SNPs are used as genetic markers for certain diseases and for pharmacology studies. Other genetic markers include VNTRs and RFLPs. 4. Four mechanisms by which the normal products of proto-oncogenes can be distrupted to rpoduce neoplastic transformation are: 1. Gene translocation 2. Gene amplification 3. Point mutations 4. Viral insertion